Cilcare

Cilcare

Recherche en biotechnologie

Montpellier, Languedoc-Roussillon 5 022 abonnés

MAKING HEARING A PRIORITY

À propos

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
11-50 employés
Siège social
Montpellier, Languedoc-Roussillon
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2014
Domaines
hearing disorders, tinnitus, hearing loss, pharmaceutical development, pharmacology, clinical development, preclinical development, GLP ototoxicology, hearing loss, tinnitus, auditory safety, ear disorders, AI et precision medicine

Lieux

Employés chez Cilcare

Nouvelles

Pages similaires

Parcourir les offres d’emploi